Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Air pollution and heart failure | Stem cells and cardiac muscle | LVAD and suicide
Tuesday, March 17, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Featured Articles

Heart-failure patients lose years of life when air pollution is a neighbor

Long-term daily exposure to air pollution carrying fine particulate matter poses a significant risk of all-cause mortality for people with heart failure (HF).

READ MORE >
Smog
Share on Twitter Share on Facebook Share on Linkedin

Heart-failure patients lose years of life when air pollution is a neighbor

Share on Twitter Share on Facebook Share on Linkedin
Smog
Long-term daily exposure to air pollution carrying fine particulate matter poses a significant risk of all-cause mortality for people with heart failure (HF).
READ MORE >

Stem cell therapy revives cardiac muscle damaged during heart attacks

The Mayo Clinic researchers were "surprised" at how far the intervention restored the diseased hearts back to normal.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Stem cell therapy revives cardiac muscle damaged during heart attacks

Share on Twitter Share on Facebook Share on Linkedin
The Mayo Clinic researchers were "surprised" at how far the intervention restored the diseased hearts back to normal.
READ MORE >

In Other News

ASNC monitoring potential Mo-99 supply shortages due to COVID-19

The president of the American Society of Nuclear Cardiology said there are no shortfalls reported at this time, but the organization is keeping an eye on the situation as more countries implement travel bans.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

ASNC monitoring potential Mo-99 supply shortages due to COVID-19

Share on Twitter Share on Facebook Share on Linkedin
The president of the American Society of Nuclear Cardiology said there are no shortfalls reported at this time, but the organization is keeping an eye on the situation as more countries implement travel bans.
READ MORE >

In Case You Missed It

LVAD recipients see heightened risk of suicide

Heart patients with implanted left ventricular assist devices are more likely to both attempt and succeed in committing suicide than other chronically ill patients, according to a study out of France.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

LVAD recipients see heightened risk of suicide

Share on Twitter Share on Facebook Share on Linkedin
Heart patients with implanted left ventricular assist devices are more likely to both attempt and succeed in committing suicide than other chronically ill patients, according to a study out of France.
READ MORE >

Hypertension ‘a key dangerous factor’ in COVID-19 mortality

Hypertensive patients may be at a greater risk of dying from COVID-19, the viral disease stemming from the world’s largest coronavirus outbreak to date, according to Bloomberg News.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Hypertension ‘a key dangerous factor’ in COVID-19 mortality

Share on Twitter Share on Facebook Share on Linkedin
Hypertensive patients may be at a greater risk of dying from COVID-19, the viral disease stemming from the world’s largest coronavirus outbreak to date, according to Bloomberg News.
READ MORE >

ACC issues COVID-19 guidance for cardiologists

Just days before the American College of Cardiology canceled its annual scientific sessions for the first time in the meeting’s 69-year history, it released a set of guidelines for cardiology care teams dealing with the COVID-19 outbreak.

READ MORE >
Coronavirus
Share on Twitter Share on Facebook Share on Linkedin

ACC issues COVID-19 guidance for cardiologists

Share on Twitter Share on Facebook Share on Linkedin
Coronavirus
Just days before the American College of Cardiology canceled its annual scientific sessions for the first time in the meeting’s 69-year history, it released a set of guidelines for cardiology care teams dealing with the COVID-19 outbreak.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme